ADmit Therapeutics
ADmit Therapeutics is focused on Alzheimer's disease (AD) early detection. ADmit Therapeutics will give diagnostic services to drug companies conducting early-stage AD clinical studies. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD37—55m (Dealroom.co estimates Oct 2023.)
Company register number B67146738
Esplugues de Llobregat Catalonia (HQ)
- hard tech
- biotechnology
- horizon europe
- woman founder
- spinout
- eit ecosystem
- eit health
- eit supernovas
- health it
- eicfund
- headstart (eit health)
- medical diagnostics
- european health catapult (eit health)
- alzheimers disease
- headstart 2018 (eit health)
- european health catapult 2018 (eit health)
- epigenetics
- caixa impulse (eit health)
- digital sandbox (eit health)
- digital sandbox 2019 (eit health)
- caixa impulse 2015 (eit health)
Authorizing premium user...